Publications by authors named "Rama Suresh"

Claim this Profile
N
Neoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer.
Patrick M Grierson, Crystal Wolf, Rama Suresh, Andrea Wang-Gillam, Benjamin R Tan

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer.
Foluso O Ademuyiwa, Cynthia X Ma, Katherine Weilbaecher, Rama Suresh, Lindsay L Peterson

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.
Xiuli Zhang, S Peter Goedegebuure, Michael Y Chen, Rashmi Mishra, Felicia Zhang, Rama Suresh

Genome Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid Trolling to Optimize A Adenosine Receptor-Positive Allosteric Modulators (PAMs).
Balaram Pradhan, Matteo Pavan, Courtney L Fisher, Veronica Salmaso, Tina C Wan, R Rama Suresh

J Med Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of metastatic rectal squamous cell carcinoma in a pregnant patient.
Nathan S Kau, Jeannie C Kelly, Hyun Kim, Radhika Smith, Tyler J Fraum, Rama Suresh

BMJ Case Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy.
Patrick M Grierson, Rama Suresh, Benjamin Tan, Katrina S Pedersen, Manik Amin

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A Adenosine Receptor Positive Allosteric Modulators.
Paola Oliva, R Rama Suresh, Silvia Pasquini, Veronica Salmaso, Edward J Will

ACS Med Chem Lett· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: a Phase I Dose Escalation and Expansion Study.
Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams, Rama Suresh, Albert C Lockhart

Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescent A and A adenosine receptor antagonists as flow cytometry probes.
Kiran S Toti, Ryan G Campbell, Hobin Lee, Veronica Salmaso, R Rama Suresh

Purinergic Signal· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assay-Dependent Inverse Agonism at the A Adenosine Receptor: When Neutral Is Not Neutral.
Eline Pottie, R Rama Suresh, Kenneth A Jacobson, Christophe P Stove

ACS Pharmacol Transl Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A adenosine receptor agonists, antagonists, inverse agonists and partial agonists.
Kenneth A Jacobson, R Rama Suresh, Paola Oliva

Int Rev Neurobiol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
Re-I Chin, Joshua P Schiff, Anup S Shetty, Katrina S Pedersen, Olivia Aranha, Rama Suresh

Dis Colon Rectum· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.
Andrew A Davis, Jingqin Luo, Tiantian Zheng, Chao Dai, Xiaoxi Dong, Rama Suresh

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma.
Patrick M Grierson, Benjamin Tan, Katrina S Pedersen, Haeseong Park, Rama Suresh

Oncologist· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A TITE-CRM Phase I Trial.
Hyun Kim, Jeffrey R Olsen, Olga L Green, Re-I Chin, William G Hawkins, Rama Suresh

Int J Radiat Oncol Biol Phys· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).
Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, Ellis Levine, Jingqin Luo, Rama Suresh

NPJ Breast Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.
Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams, Rama Suresh, Albert C Lockhart

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Activity Studies of 1-Imidazo[4,5-]quinolin-4-amine Derivatives as A Adenosine Receptor Positive Allosteric Modulators.
Lucas B Fallot, R Rama Suresh, Courtney L Fisher, Veronica Salmaso, Robert D O'Connor

J Med Chem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Dual-Acting A Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gα and Gα Isoprotein Activation.
Courtney L Fisher, Lucas B Fallot, Tina C Wan, Robert F Keyes, R Rama Suresh

ACS Pharmacol Transl Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective A Adenosine Receptor Antagonist Radioligand for Human and Rodent Species.
R Rama Suresh, Zhan-Guo Gao, Veronica Salmaso, Eric Chen, Ryan G Campbell

ACS Med Chem Lett· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiological Role and Medicinal Chemistry of A Adenosine Receptor Antagonists in Alzheimer's Disease.
Stefania Merighi, Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi, Alessia Travagli, R Rama Suresh

Molecules· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis.
Jairam Krishnamurthy, Jingqin Luo, Rama Suresh, Foluso Ademuyiwa, Caron Rigden

NPJ Breast Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of DPTN and other selective A adenosine receptor antagonists.
Zhan-Guo Gao, R Rama Suresh, Kenneth A Jacobson

Purinergic Signal· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets.
Kenneth A Jacobson, Veronica Salmaso, R Rama Suresh, Dilip K Tosh

RSC Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convergent synthesis of 2-thioether-substituted ()-methanocarba-adenosines as purine receptor agonists.
R Rama Suresh, Russell B Poe, Baorui Lin, Kexin Lv, Ryan G Campbell

RSC Adv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis